Express News | Telesis Bio Inc - on June 6 Received Nasdaq Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. vTv Therapeutics (NASDAQ:VTVT) stock i
Vicore Expands and Strengthens Its Board of Directors
STOCKHOLM, SWEDEN / ACCESSWIRE / May 14, 2024 / Vicore Pharma Holding Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of
FFIE, OGEN and CCLD Among Mid-day Movers
Telesis Bio in Jeopardy: Risks of Nasdaq Delisting and Financial Instability Loom
Express News | Telesis Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
NOTV, BFRI and CPOP Among Pre-market Losers
Telesis Bio Reports Q1 Results
10-Q: Quarterly report
Express News | Telesis Bio Q1 2024 Adj EPS $(5.52) Misses $(0.23) Estimate, Sales $3.440M Miss $6.900M Estimate
Express News | Telesis Bio Inc - Qtrly Shr Loss $5.52
Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M
04:22 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M
Press Release: Telesis Bio Reports First Quarter 2024 Financial Results
Telesis Bio Reports First Quarter 2024 Financial Results SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers
Telesis Bio 1Q Loss/Shr $5.52 >TBIO
Telesis Bio 1Q Loss/Shr $5.52 >TBIO
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
TELESIS BIO To Carry Out 1-for-18 Reverse Stock Split On May 9th, 2024
May 8th - $TELESIS BIO(TBIO.US)$ is about to implement a 1-for-18 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 9th, 2024.$TELESIS BIO(TBIO.US)$ slipp
Express News | Telesis Shares Are Trading Lower. The Company Announced a 1-for-18 Reverse Stock Split
Express News | Telesis Bio- Reverse Stock Split Is Part of Company's Plan to Regain Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq
Express News | Telesis Bio Inc - Will Effect a 1-for-18 Reverse Stock Split of Its Common Stock
No Data